Lab Angelus, Inc. filed a Form D with the Securities and Exchange Commission on 2026-08-14.
Lab Angelus, Inc. filed a Form D notice of an exempt securities offering with the SEC on August 14, 2026. The filing reports $350K sold. Its industry group is Other Technology. It names Samuel Caughron (Executive Officer, Director) (SEC Form D, August 14, 2026).
In its own words: “Lab Angelus builds the connective tissue of precision oncology — coordinating the laboratories, the clinicians, and the data on which modern cancer care depends.” (labangelus.com, checked November 1, 2026)
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Selling to Lab Angelus, Inc.? See who runs it and how to reach them, plus this week's 25 other newly funded companies.
Is this your company?
Sell to companies like Lab Angelus, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-08-14 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Lab Angelus, Inc.
Free to see. No signup.
More on the people and the money behind Lab Angelus, Inc., from the filings we hold.
Other Technology raises by companies based in Kansas, filed in August 2026, largest first.
Get an email when Lab Angelus, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Lab Angelus, Inc. raises, hires or launches. No email unless you switch it on.
Watch Lab Angelus, Inc. →Get the full cited report on Lab Angelus, Inc.
What the filing shows about Lab Angelus, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Lab Angelus, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Lab Angelus, Inc.'s address as 6740 Antioch Rd., Ste. 220, Merriam, KS 66204.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Lab Angelus, Inc. is a registered filer with the SEC (CIK 2149014) and has filed since 2026-08-14. 1 filing is on record, the latest on 2026-08-14.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Lab Angelus, Inc.'s Form D of 2026-08-14 names Samuel Caughron as its officers, directors or promoters.
Its new offerings report $350K sold across 1 offering, as its own filings state.
Trailing twelve months. 3831 filings in Other Technology, totalled by week. The dot is this raise, $350K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Samuel Caughron is named as Executive Officer and Director on the Form D that Lab Angelus, Inc. filed with the SEC on 14 August 2026, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2026-08-14 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Lab Angelus, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Lab Angelus, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Lab Angelus, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Lab Angelus, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Lab Angelus, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Lab Angelus, Inc.. With no account yet, you sign up free and land on the result.
On these lists: The rest of the US raises, week of 2026-08-10 · AI and software raises, week of 2026-08-10
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/lab-angelus-inc-form-d-26000002